Co-localization of insulin-like growth factor binding protein 3 and fibronectin in human articular cartilage

Osteoarthritis and Cartilage

Volumn 10, Issue 7, 2002, Pages 556-563

  Martin, J A ^a   Miller, B A ^a   Scherb, M B ^a   Lembke, L A ^a   Buckwalter, J A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; COLLAGEN TYPE 4; FIBRONECTIN; PROTEOHEPARAN SULFATE; SCLEROPROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TENASCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DIFFUSION; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; INFANT; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM;

EID: 0036638040     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.2002.0791     Document Type: Article

References (55)

1. Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage
2. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants
3. Insulin like growth factor I can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines
4. Growth factor actions on articular cartilage
5. The age-related decline in chondrocyte response to insulin-like growth factor-I: The roles of growth factor binding proteins
6. Chondrocyte unresponsiveness to insulin-like growth factor-I: A novel pathogenic mechanism for cartilage destruction in experimental arthritis
7. Growth promoting peptides in osteoarthritis: Insulin, insulin-like growth factor-1, growth hormone
8. Effects of catabolic and anabolic cytokines on proteoglycan biosynthesis in young, old and osteoarthritic canine cartilage
9. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins
10. Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4
11. Normal expression of type 1 insulin-like growth factor receptor by human osteoarthritic chondrocytes with increased expression and synthesis of insulin-like growth factor binding proteins
12. Insulin-like growth factors and their binding proteins: Biological actions
13. The role and content of endogenous insulin-like growth factor-binding proteins in bovine articular cartilage
14. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis
15. Regulation and physiological role of insulin-like growth factor binding proteins
16. General aspects of insulin-like growth factor binding proteins
17. Production of insulin-like growth factors and their binding proteins by rabbit articular chondrocytes: Relationships with cell multiplication
18. The 25 kDa insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro
19. Insulin like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins
20. Elevated levels of insulin-like growth factor (IGF) binding protein-3 in rheumatoid arthritis synovial fluid inhibit stimulation by IGF-I of articular chondrocyte proteoglycan synthesis
21. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I
22. Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I
23. Insulin-like growth factor binding proteins as glucoregulators
24. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells
25. Insulin-like growth factor binding proteins: Gene structure and expression
26. Prostaglandin E2 up-regulates insulin-like growth factor binding protein-3 expression and synthesis in human articular chondrocytes by a c-AMP-independent pathway: Role of calcium and protein kinase A and C
27. Production and hormonal regulation of insulin-like growth factor binding proteins in bovine chondrocytes
28. Effects of interleukin-1 beta on the insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes
29. Interleukin-1 and tumor necrosis factor -alpha increase insulin-like growth factor binding protein-3 (IGFBP3) production and IGFBP-3 protease activity in human articular chondrocytes
30. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes
31. Altered ligand specificity of proteolyzed insulin-like growth factor binding protein-3
32. Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3): A physiological mechanism in the regulation of IGF bio-availability
33. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells
34. IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding, and structure of fragments
35. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid
36. Structure-function relationships in the heparin-binding C-terminal region of insulin-like growth factor binding protein-3
37. Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5
38. Induction of chondrogenesis in limb mesenchymal cultures by disruption of the actin cytoskeleton
39. An immuno-histochemical study of fibronectin in human osteoartritic and disease-free articular cartilage
40. Ultrastructural localization of fibronectin in human osteoarthritic articular cartilage
41. Biosynthesis and distribution of fibronectin in normal and osteoarthritic human cartilage
42. Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis
43. Cartilage-specific collagens
44. Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage
45. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin like growth factor-I and insulin like growth factor binding protein complexes
46. ADAM 12, a disintetegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3
47. Expression of the EDB fibronectin isoform in adult human articular cartilage
48. Splicing patterns of fibronectin mRNA from normal and osteoarthritic human articular cartilage
49. Increased expression of the ED-B-containing fibronectin (an embryonic isoform of fibronectin) in human osteoarthritic cartilage
50. Cartilage fibronectin isoforms: In search of functions for a special population of matrix glycoproteins
51. Fibronectin as a marker for osteoarthritis
52. High concentrations of fibronectin fragments cause short-term catabolic effects in cartilage tissue while lower concentrations cause continuous anabolic effects
53. Exposure of cartilage to a fibronectin fragment amplifies catabolic processes while also enhancing anabolic processes to limit damage
54. Effects of fibronectin on articular cartilage chondrocyte proteoglycan synthesis and response to insulin-like growth factor-I
55. Interaction of the small proteoglycan decorin with fibronectin. Involvement of the sequence NKISK of the core protein